Pre-hospital heparin ‘may improve coronary reperfusion’
Aus researchers say their study has set the scene for a trial that could change practice
AusDoc brings you the latest news from the Cardiac Society of Australia and New Zealand virtual annual scientific meeting (CSANZ 2021).
Patients with ST-elevation myocardial infarction (STEMI) given heparin by paramedics before hospitalisation experienced fewer occluded arteries with no increased risk of major bleeds, a landmark Australian study shows.
In the world-first study, Melbourne researchers say they have demonstrated that pre-hospital use of the anticoagulant is both a safe and highly effective treatment option.
Study first author Dr Jason Bloom, a cardiology registrar at Alfred Health, Melbourne, presented the findings last week at CSANZ 2021.
